CA2028629A1 - Compositions pharmaceutiques efficaces de facon antiandrogenique - Google Patents

Compositions pharmaceutiques efficaces de facon antiandrogenique

Info

Publication number
CA2028629A1
CA2028629A1 CA2028629A CA2028629A CA2028629A1 CA 2028629 A1 CA2028629 A1 CA 2028629A1 CA 2028629 A CA2028629 A CA 2028629A CA 2028629 A CA2028629 A CA 2028629A CA 2028629 A1 CA2028629 A1 CA 2028629A1
Authority
CA
Canada
Prior art keywords
antiandrogenically
pharmaceutical compositions
effective pharmaceutical
preparations
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2028629A
Other languages
English (en)
Other versions
CA2028629C (fr
Inventor
Georg Rossling
Andreas Sachse
Jutta Riedl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2028629A1 publication Critical patent/CA2028629A1/fr
Application granted granted Critical
Publication of CA2028629C publication Critical patent/CA2028629C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002028629A 1989-10-27 1990-10-26 Compositions pharmaceutiques efficaces de facon antiandrogenique Expired - Fee Related CA2028629C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3936328A DE3936328A1 (de) 1989-10-27 1989-10-27 Pharmazeutische praeparate
DEP3936328.7 1989-10-27

Publications (2)

Publication Number Publication Date
CA2028629A1 true CA2028629A1 (fr) 1991-04-28
CA2028629C CA2028629C (fr) 2000-12-19

Family

ID=6392630

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002028629A Expired - Fee Related CA2028629C (fr) 1989-10-27 1990-10-26 Compositions pharmaceutiques efficaces de facon antiandrogenique

Country Status (15)

Country Link
US (1) US5723146A (fr)
EP (1) EP0451237B1 (fr)
JP (1) JP3011762B2 (fr)
AT (1) ATE103804T1 (fr)
AU (1) AU6553790A (fr)
CA (1) CA2028629C (fr)
DE (2) DE3936328A1 (fr)
DK (1) DK0451237T3 (fr)
FI (1) FI913100A7 (fr)
GR (1) GR900100772A (fr)
HU (1) HU215127B (fr)
IE (1) IE903859A1 (fr)
NO (1) NO912435L (fr)
PT (1) PT95697B (fr)
WO (1) WO1991006284A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
DE19916384A1 (de) * 1999-03-31 2000-10-05 Schering Ag Cyproteronacetat, Chlormadinonacetat oder 17alpha-Propylmesterolon enthaltende, bioerosive Mikropartikeln, Verfahren zu deren Herstellung, therapeutische Verwendung dieser in topischen Arzneiformen
JP3466516B2 (ja) 1999-09-07 2003-11-10 科学技術振興事業団 安定保存可能な酸素輸液剤
EP1316317A1 (fr) * 2001-11-30 2003-06-04 University of Liege Associations hydrosolubles à base de cyprotérone et/ou d'un ester de celle-ci, leurs préparations et leurs utilisations
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
EP1643971A2 (fr) * 2003-05-22 2006-04-12 Neopharm, Inc. Formulations liposomales combinees
US20050095283A1 (en) * 2003-09-16 2005-05-05 Aphios Corporation Compositions and methods for topically treating diseases
AU2005282571A1 (en) * 2004-09-03 2006-03-16 Piedmont Pharmaceuticals, Llc Methods for transmembrane treatment and prevention of otitis media
CA2622001A1 (fr) * 2005-09-26 2007-04-05 Piedmont Pharmaceuticals Llc Procedes de traitement et de prevention de l'otite moyenne par le biais d'agents qui ameliorent la penetration chimique pour faciliter la delivrance de medicament transmembranairedans l'oreille moyenne
WO2007037886A2 (fr) * 2005-09-26 2007-04-05 Piedmont Pharmaceuticals Llc Procedes de traitement et de prevention de l'otite moyenne par le biais de tensioactifs non ioniques pour faciliter la delivrance de medicament transmembranaire dans l'oreille moyenne
DE102006062120A1 (de) 2006-12-22 2008-06-26 Grünenthal GmbH Pharmazeutische Zusammensetzung zur Aknebehandlung
EP2165694B8 (fr) * 2007-05-29 2017-11-08 Pola Chemical Industries Inc. Vésicule utile pour une préparation externe pour la peau et préparation externe pour la peau comprenant la vésicule
JP2012505253A (ja) * 2008-10-10 2012-03-01 テバ ウィメンズ ヘルス インコーポレイテッド 低用量酢酸シプロテロンを用いる、去勢された前立腺癌患者における血管運動症状の治療方法
ITMI20110644A1 (it) * 2011-04-14 2012-10-15 Giuliani Spa Sistema per il rilascio prolungato di agenti cosmetici

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728364A (en) * 1971-07-27 1973-04-17 Syntex Corp Preparation of 17alpha-propadienyl steroids
GB1570524A (en) * 1976-03-11 1980-07-02 Unilever Ltd Cosmetic
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
GB2112730B (en) * 1981-09-30 1985-12-18 Nat Res Dev Encapsulated particles
DE3416978A1 (de) * 1983-05-12 1984-12-06 Stauffer Chemical Co., Westport, Conn. Durch liposom vermittelte transformation eukaryotischer zellen
EP0240630A3 (fr) * 1986-04-10 1989-01-25 University Of Miami Traitement de l'hyperandrogénie de la peau utilisant des compositions contenant du pregnénolone
WO1986001402A1 (fr) * 1984-09-05 1986-03-13 Schering Aktiengesellschaft Moyens de traitement du phenomene d'androgenisation et utilisation d'antiandrogenes pour leur production
IT1199625B (it) * 1985-01-08 1988-12-30 Finchimica Srl Uso terapeutico del ciproterone acetato
FR2619505B1 (fr) * 1987-08-20 1990-08-31 Dior Christian Parfums Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs

Also Published As

Publication number Publication date
GR900100772A (el) 1992-03-20
WO1991006284A1 (fr) 1991-05-16
IE903859A1 (en) 1991-05-08
AU6553790A (en) 1991-05-02
US5723146A (en) 1998-03-03
FI913100A0 (fi) 1991-06-25
HU907959D0 (en) 1991-11-28
NO912435D0 (no) 1991-06-21
JPH04503676A (ja) 1992-07-02
JP3011762B2 (ja) 2000-02-21
NO912435L (no) 1991-06-21
EP0451237A1 (fr) 1991-10-16
EP0451237B1 (fr) 1994-04-06
CA2028629C (fr) 2000-12-19
HUT57590A (en) 1991-12-30
DE59005281D1 (de) 1994-05-11
DE3936328A1 (de) 1991-05-02
DK0451237T3 (da) 1994-07-18
PT95697B (pt) 1997-09-30
FI913100A7 (fi) 1991-06-25
ATE103804T1 (de) 1994-04-15
HU215127B (hu) 1998-09-28
PT95697A (pt) 1991-09-13

Similar Documents

Publication Publication Date Title
AU7180387A (en) Topical antimicrobial pharmaceutical compositions and methods
CA2068324A1 (fr) Compositions peptidiques renfermant un metal et methodes de stimulation de la croissance des cheveux
CA2028629A1 (fr) Compositions pharmaceutiques efficaces de facon antiandrogenique
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
AU6974191A (en) Stable cream and lotion bases for lipophilic drug compositions
FI903382A7 (fi) Tooppisesti annettavat farmaseuttiset valmisteet
AU1795383A (en) Pharmaceutical preparations having analgetic and cytostatic activity
AU5561690A (en) Improvements in or relating to pharmaceutical preparations
IT1240473B (it) Procedimento per migliorare l'efficacia terapeutica di corticosteroidi liposolubili e composizione per l'attuazione di tale procedimento
IT1224574B (it) Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono
AU3760789A (en) Topical cosmetic and pharmaceutical preparation
HUT49370A (en) Process for producing polypeptides and pharmaceutical compositions comprising same as active ingredient
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
IL105000A0 (en) Imidazolyl-substituted phenylacetamides,their preparation and pharmaceutical compositions containing them
AU5252090A (en) Improvements in and relating to pharmaceutical formulations
ZA961050B (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them
IL82726A (en) Pharmaceutical compositions comprising anticonvulsively active 1-phenalkylimidazole-4-and/or-5-carboxamides and certain novel phenalkylimidazoles and their manufacture
ZA961314B (en) Substituted benzenesulfonylureas and -thioreas processes for their preparation their use for the production of pharmaceutical preparations and medicaments containing them
AU6236090A (en) Pharmaceutical preparations
HUT49112A (en) Process for producing new 1-aryloxy-3-amino-2-propanols and pharmaceutical compositions comprising such active ingredient
AU625769B2 (en) 2-ethoxymethyl-5-hydroxy-gamma-pyrone and melanogenesis- inhibiting endermic preparation containing the same compound as active ingredient
AU6271490A (en) Anti-inflammatory active ingredients for cosmetic preparations
AU5908790A (en) Topical pharmaceutical compositions
AU7279887A (en) Aluminium-hydrogen-oxygen complex and pharmaceutical/cosmetic compositions thereof
IL94084A0 (en) Naphthalenyl-3h-1,2,3,5-oxathiazole 2-oxides,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed